Nordette Related Published Studies
Well-designed clinical trials related to Nordette (Levonorgestrel / Estradiol)
Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers. [2011.08]
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables. [2006.07]
Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers. [2001.12]
A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills. [1993.02]
A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study. [1993.01]
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. [1992.06]
Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol. [1990.01]
Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. [1983.05]
Well-designed clinical trials possibly related to Nordette (Levonorgestrel / Estradiol)
Comparative biochemical studies on steroidogenic compounds in chickens. [2010.10]
Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients. [2010.09]
Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization. [2009.08]
[The influence of sequential hormonal therapy on biochemical and cardiovascular indices in menopause] [2008]
Effect of oral contraceptive with and without associated estriol on ultrasound measurements of breast fibroadenoma: randomized clinical trial. [2007.09.06]
Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. [2006.12]
Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. [2005.07]
Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile. [2004.06]
A multicenter, randomized study of an extended cycle oral contraceptive. [2003.08]
Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. [2003.04]
Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. [2003.01]
Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women. [2002.07]
Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. [2001.11]
A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolism. [2001.10]
Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. [2001.06]
Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). [2001]
A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. [1998.08]
The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. [1998.02]
Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients. [1997.11]
A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive. [1997.09]
Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin). [1996.06]
Changes in androgens during treatment with four low-dose contraceptives. [1996.03]
The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women. [1995.12]
A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. [1994.09]
A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial. [1993.08]
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. [1993.06]
A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. [1993.02]
Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities. [1993]
Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. [1992.11]
Long-term profile of a new progestin. [1992]
Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion. [1991.07]
Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. [1990.12]
Cycle control on low-dose oral contraceptives: a comparative trial. [1990.09]
The effect of olestra on systemic levels of oral contraceptives. [1990.07]
Initial selection of oral contraceptives. [1990.05]
Comparative study on the effect of Diane and Microgynon 50 contraceptive on the haemostatic mechanisms in Chinese subjects. [1990.04]
A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. [1990.03]
A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50. [1990.03]
Hemorheological effects of oral contraceptives. [1989.11]
Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization. [1989.06]
Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial. [1989.05]
Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function. [1989.04]
Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. [1989.01]
The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. [1987.02]
The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. [1984.04]
Other research related to Nordette (Levonorgestrel / Estradiol)
A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation. [2008.03]
Levonorgestrel as an emergency contraceptive drug. [2003.11]
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study. [1995.04]
Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations. [1992]
Other possibly related research studies
[Ectopia of cervix of the uterus and hormonal contraception] [2006.12]
Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. [2006.07]
Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. [2006.03]
Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed. [2005]
Peliosis hepatis revealed by biliary colic in a patient with oral contraceptive use. [2004.11]
Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen. [2005.01]
[Experimental study on estrogenic function of triphasic contraceptive tablets] [2003.01]
Measuring performance during the menstrual cycle: a model using oral contraceptives. [2004.01]
Triphasic oral contraceptive treatment alters the behavior and neurobiology of female cynomolgus monkeys. [2004.01]
[Occurrence of bleeding in women using combined hormonal contraceptives (ethinylestradiol 35 micrograms/norgestimate 250 micrograms in relation to regularity of administration and cycle start day] [2003.03]
A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new users. [2003.01]
Oral contraceptive-induced central retinal artery occlusion. [2002.08]
Renal papillary necrosis as first presentation of a Nigerian sickle cell patient. [2002.04]
Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. [2002.07]
Contraceptive applications of estrogen. [2002.05]
Biphasic versus triphasic oral contraceptives for contraception. [2002.05]
Hormonal effects of Depo-Provera in cervical smears: a comparison with Triphasil and postmenopausal effects. [2002.04.25]
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). [2002.02]
The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity. [2002.01]
Rapid improvement of icterus and pruritus by the oral administration of colestimide in two cases of drug-induced hepatitis. [2001.11]
[Hormonal correction of the resident microflora of the vagina and uterus cervix in women with chronic cervicitis] [2001.07]
Rapid disappearance of hepatic adenoma after contraceptive withdrawal. [2001.09]
Testing the tyrosine/catecholamine hypothesis of oral contraceptive-induced psychological side-effects: a controlled study on triphasil. [2001]
Knowledge of emergency contraception among pharmacists and doctors in Durban, South Africa. [2001.03]
Oral contraceptives in the treatment of acne. [2001.02]
[Tri-Regol and its application in gynecological practice] [2000]
Ectopic gestation following emergency contraceptive pill administration. [2000.11]
[Changes in the concentration of individual proteins in women using current peroral contraceptives] [1999]
Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients. [1999.09]
[Current monophasic hormonal contraception] [1998]
Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. [1998.11]
Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? [1998.09]
Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives. [1998.10]
Nutritional and psychological status of young women after a short-term use of a triphasic contraceptive steroid preparation. [1998]
[The use and effects of postcoital contraception] [1997.10.15]
The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness. [1997.03]
Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. [1996.12]
Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills. [1996.12]
Emergency postcoital treatment: practical and ethical barriers to use. [1996.09]
Erythema multiforme. [1996.03]
Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles. [1996]
Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. [1995.11]
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. [1994.11]
Postcoital contraception. Has its day come? [1994.11]
|
